JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M708839200 on February 13, 2008

J. Biol. Chem., Vol. 283, Issue 15, 9787-9796, April 11, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/15/9787    most recent
M708839200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Taylor, E. B.
Right arrow Articles by Goodyear, L. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, E. B.
Right arrow Articles by Goodyear, L. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Discovery of TBC1D1 as an Insulin-, AICAR-, and Contraction-stimulated Signaling Nexus in Mouse Skeletal Muscle*

Eric B. Taylor{ddagger}§, Ding An{ddagger}§, Henning F. Kramer{ddagger}§, Haiyan Yu{ddagger}§, Nobuharu L. Fujii{ddagger}§, Katja S. C. Roeckl{ddagger}§, Nicole Bowles{ddagger}§, Michael F. Hirshman{ddagger}§, Jianxin Xie, Edward P. Feener§||, and Laurie J. Goodyear{ddagger}§1

From the The Joslin Diabetes Center Section on {ddagger}Metabolism and ||Proteomics Core and §Harvard Medical School, Boston, Massachusetts 02215 and Cell Signaling Technology, Inc., Danvers, Massachusetts 01923

The Akt substrate of 160 kDa (AS160) is phosphorylated on Akt substrate (PAS) motifs in response to insulin and contraction in skeletal muscle, regulating glucose uptake. Here we discovered a dissociation between AS160 protein expression and apparent AS160 PAS phosphorylation among soleus, tibialis anterior, and extensor digitorum longus muscles. Immunodepletion of AS160 in tibialis anterior muscle lysates resulted in minimal depletion of the PAS band at 160 kDa, suggesting the presence of an additional PAS immunoreactive protein. By immunoprecipitation and mass spectrometry, we identified this protein as the AS160 paralog TBC1D1, an obesity candidate gene regulating GLUT4 translocation in adipocytes. TBC1D1 expression was severalfold higher in skeletal muscles compared with all other tissues and was the dominant protein detected by the anti-PAS antibody at 160 kDa in tibialis anterior and extensor digitorum longus but not soleus muscles. In vivo stimulation by insulin, contraction, and the AMP-activated protein kinase (AMPK) activator AICAR increased TBC1D1 PAS phosphorylation. Using mass spectrometry on TBC1D1 from mouse skeletal muscle, we identified several novel phosphorylation sites on TBC1D1 and found the majority were consensus or near consensus sites for AMPK. Semiquantitative analysis of spectra suggested that AICAR caused greater overall phosphorylation of TBC1D1 sites compared with insulin. Purified Akt and AMPK phosphorylated TBC1D1 in vitro, and AMPK, but not Akt, reduced TBC1D1 electrophoretic mobility. TBC1D1 is a major PAS immunoreactive protein in skeletal muscle that is phosphorylated in vivo by insulin, AICAR, and contraction. Both Akt and AMPK phosphorylate TBC1D1, but AMPK may be the more robust regulator.


Received for publication, October 26, 2007 , and in revised form, February 6, 2008.

* This research was supported by National Institutes of Health Grants AR42238 and AR45670 (to L. J. G.), Individual Kirschstein National Research Service Award F32 DK075851 (to E. B. T.), Joslin Diabetes Center Diabetes and Endocrinology Research Center Grant DK36836, Canadian Institutes of Health Research Fellowship MFE-83802, and Canadian Diabetes Association Incentive Award PF-3-07-2255-DA (to D. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: One Joslin Place, Boston, MA 02215. Tel.: 617-732-2573; Fax: 617-732-2650; E-mail: laurie.goodyear{at}joslin.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.